{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:15:57Z","timestamp":1792066557073,"version":"4.4.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","award":["C1034211"],"award-info":[{"award-number":["C1034211"]}],"id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","award":["C1051004"],"award-info":[{"award-number":["C1051004"]}],"id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.intimp.2022.109585","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T18:46:12Z","timestamp":1671129972000},"page":"109585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Kaempferol modulates IFN-\u03b3 induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesions"],"prefix":"10.1016","volume":"114","author":[{"given":"Yanpeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kutty Selva","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109585_b0005","unstructured":"D. Lee, Perspectives Toward Seeking Treatment Among Patients With Psoriasis: Protocol for a Twitter Content Analysis, J. Med. Internet Res. 23(2) (2021) N.PAG-N.PAG."},{"issue":"1","key":"10.1016\/j.intimp.2022.109585_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.gene.6364351","article-title":"Psoriasis: genetic associations and immune system changes","volume":"8","author":"Liu","year":"2007","journal-title":"Genes Immun."},{"issue":"2","key":"10.1016\/j.intimp.2022.109585_b0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/pcmedi\/pbz011","article-title":"Genetics of psoriasis: a basis for precision medicine","volume":"2","author":"Ran","year":"2019","journal-title":"Precis Clin. Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.109585_b0020","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","volume":"80","author":"Menter","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2022.109585_b0025","first-page":"77","article-title":"Conventional therapies for psoriasis","volume":"59","author":"Rebora","year":"2007","journal-title":"Reumatismo"},{"key":"10.1016\/j.intimp.2022.109585_b0030","article-title":"Plasma miR-126 expression correlates with risk and severity of psoriasis and its high level at baseline predicts worse response to Tripterygium wilfordii Hook F in combination with acitretin","volume":"115","author":"Duan","year":"2019","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.intimp.2022.109585_b0035","doi-asserted-by":"crossref","first-page":"2623085","DOI":"10.1155\/2018\/2623085","article-title":"Efficacy and Safety of Tripterygium Wilfordii Hook F on Psoriasis Vulgaris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"2018","author":"Lv","year":"2018","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.intimp.2022.109585_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153299","article-title":"Role of keratinocytes and immune cells in the anti-inflammatory effects of Tripterygium wilfordii Hook. f. in a murine model of psoriasis","volume":"77","author":"Ru","year":"2020","journal-title":"Phytomed.: Int. J. Phytotherapy Phytopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109585_b0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4103\/0366-6999.151069","article-title":"Efficacy and safety of Tripterygium wilfordii hook F versus acitretin in moderate to severe psoriasis vulgaris: a randomized clinical trial","volume":"128","author":"Wu","year":"2015","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.intimp.2022.109585_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2015.05.002","article-title":"Kaempferol and inflammation: From chemistry to medicine","volume":"99","author":"Devi","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109585_b0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ptr.6227","article-title":"Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review","volume":"33","author":"Imran","year":"2019","journal-title":"Phytotherapy Research : PTR"},{"issue":"2","key":"10.1016\/j.intimp.2022.109585_b0060","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.intimp.2015.03.044","article-title":"Kaempferol enhances the suppressive function of Treg cells by inhibiting FOXP3 phosphorylation","volume":"28","author":"Lin","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109585_b0065","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/ajt.13261","article-title":"Kaempferol Promotes Transplant Tolerance by Sustaining CD4+FoxP3+ Regulatory T Cells in the Presence of Calcineurin Inhibitor","volume":"15","author":"Zeng","year":"2015","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"3","key":"10.1016\/j.intimp.2022.109585_b0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cei.13363","article-title":"Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model","volume":"198","author":"Liu","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2022.109585_b0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of Psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2022.109585_b0080","first-page":"S6","article-title":"Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis","volume":"127","author":"Guttman-Yassky","year":"2007","journal-title":"J, Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109585_b0085","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2022.109585_b0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2022.109585_b0095","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/08830185.2013.863306","article-title":"Phenotypic and functional plasticity of gamma-delta (gammadelta) T cells in inflammation and tolerance","volume":"33","author":"Paul","year":"2014","journal-title":"Int. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109585_b0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cell. Mol. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109585_b0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/08916934.2016.1166214","article-title":"New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis","volume":"49","author":"Karczewski","year":"2016","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.intimp.2022.109585_b0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nri3384","article-title":"Six-of-the-best: unique contributions of gammadelta T cells to immunology","volume":"13","author":"Vantourout","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2022.109585_b0115","doi-asserted-by":"crossref","unstructured":"S.C. Albanesi C, Sebastiani S et al. , A cytokineto\u2010chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases, J. Leukocyte Biol. 70 (2001) 617\u2013623.","DOI":"10.1189\/jlb.70.4.617"},{"key":"10.1016\/j.intimp.2022.109585_b0120","doi-asserted-by":"crossref","unstructured":"G.M. Federici M, Scarponi C, Girolomoni G, Albanesi C., Impaired IFN\u2010\u03b3\u2010dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling, J. Immunol. 168 (2002) 434\u2013442.","DOI":"10.4049\/jimmunol.169.1.434"},{"issue":"260","key":"10.1016\/j.intimp.2022.109585_b0125","first-page":"tr8","article-title":"The Jak-STAT pathway stimulated by interferon gamma","volume":"2004","author":"Horvath","year":"2004","journal-title":"Science's STKE: Signal Transduction Knowledge Environment"},{"issue":"7","key":"10.1016\/j.intimp.2022.109585_b0130","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/eji.201343748","article-title":"Therapeutic hope for psoriasis offered by SOCS (suppressor of cytokine signaling) mimetic peptide","volume":"43","author":"Kubo","year":"2013","journal-title":"Eur J. Immunol."},{"key":"10.1016\/j.intimp.2022.109585_b0135","doi-asserted-by":"crossref","unstructured":"S.C. Madonna S, Sestito R, Pallotta S, Cavani A, Albanesi C, The IFN-gamma-dependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Kr\u00fcppel-like factor-4, and it is dysregulated in psoriatic keratinocytes, J Immunol 185(4) (2010) 2467-81.","DOI":"10.4049\/jimmunol.1001426"},{"issue":"12","key":"10.1016\/j.intimp.2022.109585_b0140","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s00105-019-04509-x","article-title":"[Pharmacology of Janus kinase inhibitors], Der Hautarzt","volume":"70","author":"Solimani","year":"2019","journal-title":"Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete"},{"key":"10.1016\/j.intimp.2022.109585_b0145","unstructured":"J.S. Du Y, Cheng L, Liu J, JAK\/STAT and VEGF\/PAK1 signaling as emerging targets for topical treatment of psoriasis: a pilot study, Int J Clin Exp Pathol 13(12) (2020) 3111-3119."},{"key":"10.1016\/j.intimp.2022.109585_b0150","doi-asserted-by":"crossref","unstructured":"G.-A.P. G\u00f3mez-Garc\u00eda F, Montilla-L\u00f3pez A, Hern\u00e1ndez-Parada J, Sanz-Cabanillas JL, Ruano J, Parra-Peralbo E, A Scoping Review on Use of Drugs Targeting the JAK\/STAT Pathway in Psoriasis, Frontiers in medicine 9 (2022).","DOI":"10.3389\/fmed.2022.754116"},{"issue":"7","key":"10.1016\/j.intimp.2022.109585_b0155","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrd1441","article-title":"A new modality for immunosuppression: targeting the JAK\/STAT pathway","volume":"3","author":"O'Shea","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2022.109585_b0160","doi-asserted-by":"crossref","unstructured":"N.R. H\u00e4m\u00e4l\u00e4inen M, Vuorela P, Heinonen M, Moilanen E, Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages, Mediators Inflamm (2007).","DOI":"10.1155\/2007\/45673"},{"issue":"2","key":"10.1016\/j.intimp.2022.109585_b0165","article-title":"The Involvement of Oxidative Stress in Psoriasis. A Systematic Review","volume":"11","author":"Dobrica","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"8","key":"10.1016\/j.intimp.2022.109585_b0170","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/10715762.2019.1648800","article-title":"Oxidative stress involvement in psoriasis: a systematic review","volume":"53","author":"Cannavo","year":"2019","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.intimp.2022.109585_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.714897","article-title":"Mitochondrial Reactive Oxygen Species Are Essential for the Development of Psoriatic Inflammation","volume":"12","author":"Mizuguchi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.109585_b0180","doi-asserted-by":"crossref","unstructured":"M.V. Medovic, Jakovljevic, V. L., Zivkovic, V. I., Jeremic, N. S., Jeremic, J. N., Bolevich, S. B., Ravic Nikolic, A. B., Milicic, V. M., & Srejovic, I. M, Psoriasis between Autoimmunity and Oxidative Stress: Changes Induced by Different Therapeutic Approaches, Oxidative medicine and cellular longevity (2022).","DOI":"10.1155\/2022\/2249834"},{"issue":"6","key":"10.1016\/j.intimp.2022.109585_b0185","doi-asserted-by":"crossref","first-page":"C1640","DOI":"10.1152\/ajpcell.1998.275.6.C1640","article-title":"Activation of the JAK-STAT pathway by reactive oxygen species","volume":"275","author":"Simon","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.intimp.2022.109585_b0190","doi-asserted-by":"crossref","unstructured":"C.M. Marzaioli V, Floudas A, Wade SC, Low C, Veale DJ, Fearon U, Monocyte-Derived Dendritic Cell Differentiation in Inflammatory Arthritis Is Regulated by the JAK\/STAT Axis via NADPH Oxidase Regulation, Frontiers in immunology 11 (2020) 1406.","DOI":"10.3389\/fimmu.2020.01406"},{"key":"10.1016\/j.intimp.2022.109585_b0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminf."},{"key":"10.1016\/j.intimp.2022.109585_b0200","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4939-7201-2_18","article-title":"Docking and Virtual Screening in Drug Discovery","volume":"1647","author":"Kontoyianni","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109585_b0205","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.intimp.2022.109585_b0210","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","article-title":"Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes","volume":"139","author":"Moos","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109585_b0215","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1515\/jbcpp-2020-0112","article-title":"Strain specific response of mice to IMQ-induced psoriasis","volume":"32","author":"Badanthadka","year":"2021","journal-title":"J. Basic. Clin. Physiol Pharmacol"},{"key":"10.1016\/j.intimp.2022.109585_b0220","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.intimp.2017.01.023","article-title":"Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-kappaB expression","volume":"44","author":"Han","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2022.109585_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108160","article-title":"Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation","volume":"100","author":"Shokrian Zeini","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2022.109585_b0230","doi-asserted-by":"crossref","unstructured":"S.A. Kadam DP, R.D. Ankush, C.Y. Kadam, Deshpande KH, Role of oxidative stress in various stages of psoriasis, Indian J Clin Biochem 25(4) (2010) 388-92.","DOI":"10.1007\/s12291-010-0043-9"},{"key":"10.1016\/j.intimp.2022.109585_b0235","doi-asserted-by":"crossref","unstructured":"L.X. Tu Hongqin, Gu Heng, Xu Lanfang, Wang Yongfang and Song Shasha, Triptolide Inhibits IFN-\u03b3 Signaling via the Jak\/STAT Pathway in HaCaT Keratinocytes, Phytother. Res 25 (2011) 1678\u20131685.","DOI":"10.1002\/ptr.3471"},{"issue":"Pt 16","key":"10.1016\/j.intimp.2022.109585_b0240","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1242\/jcs.113.16.2813","article-title":"SOCS: physiological suppressors of cytokine signaling","volume":"113","author":"Krebs","year":"2000","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.intimp.2022.109585_b0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00024382-200202000-00001","article-title":"Suppressors of cytokine signaling (SOCS): inhibitors of the JAK\/STAT pathway","volume":"17","author":"Cooney","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.intimp.2022.109585_b0250","doi-asserted-by":"crossref","unstructured":"M.S. van der Fits L, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E, Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis, Journal of immunology research 182(9) (2009) 5836-5845.","DOI":"10.4049\/jimmunol.0802999"},{"issue":"3","key":"10.1016\/j.intimp.2022.109585_b0255","doi-asserted-by":"crossref","first-page":"254","DOI":"10.23736\/S0026-4806.20.06460-5","article-title":"Treatment of psoriasis: janus kinases inhibitors and biologics for the interleukin-23\/Th17 axis","volume":"111","author":"Sun","year":"2020","journal-title":"Minerva Med."},{"key":"10.1016\/j.intimp.2022.109585_b0260","doi-asserted-by":"crossref","unstructured":"D.T. Xie XJ, Wang Y, Wang MX, Meng YJ, Lin Y, Xu XL, Li P, Zhao JX, Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing \u03b3\u03b4 T cells, Molecular immunology 101 (2018) 386-395.","DOI":"10.1016\/j.molimm.2018.07.011"},{"issue":"7","key":"10.1016\/j.intimp.2022.109585_b0265","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.4049\/jimmunol.1400205","article-title":"Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23\/IL-17 axis","volume":"193","author":"Works","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2022.109585_b0270","doi-asserted-by":"crossref","unstructured":"N.R. Rea MS, M.G. Figueiro, Modeling Circadian Phototransduction: Quantitative Predictions of Psychophysical Data, Front Neurosci 15 (2021).","DOI":"10.3389\/fnins.2021.615322"},{"key":"10.1016\/j.intimp.2022.109585_b0275","doi-asserted-by":"crossref","unstructured":"X.Y. Song CY, Y.Q. Lu, Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects, J Zhejiang Univ Sci B 21(4) (2020) 280-290.","DOI":"10.1631\/jzus.B1900607"},{"issue":"1","key":"10.1016\/j.intimp.2022.109585_b0280","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13075-018-1563-6","article-title":"Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study","volume":"20","author":"Zhou","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2022.109585_b0285","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3389\/fphar.2019.01250","article-title":"Adverse Events Associated With Treatment of Tripterygium wilfordii Hook F: A Quantitative Evidence Synthesis","volume":"10","author":"Ru","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109585_b0290","first-page":"220","article-title":"Jak-STAT signaling pathways in cells of the immune system","volume":"2","author":"Ivashkiv","year":"2000","journal-title":"Rev. Immunogenet"},{"issue":"1","key":"10.1016\/j.intimp.2022.109585_b0295","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4049\/jimmunol.169.1.434","article-title":"Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1","volume":"169","author":"Federici","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2022.109585_b0300","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1038\/cddis.2012.69","article-title":"Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis","volume":"3","author":"Madonna","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2022.109585_b0305","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3389\/fimmu.2017.00825","article-title":"Editorial: The Dynamic Role of Suppressor of Cytokine Signaling Proteins in the Regulation of Immune and Autoimmune Responses","volume":"8","author":"Johnson","year":"2017","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109585_b0310","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach","volume":"18","author":"Tanaka","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109585_b0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/1744666X.2022.2039121","article-title":"Comparing available JAK inhibitors for treating patients with psoriasis","volume":"18","author":"Funk","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2022.109585_b0320","doi-asserted-by":"crossref","unstructured":"K.Y. Schwartz DM, A. Villarino, M. Ward, M. Gadina, J.J. O'Shea, JAK inhibition as a therapeutic strategy for immune and inflammatory diseases, Nature reviews. Drug discovery 16 (2017) 843-862.","DOI":"10.1038\/nrd.2017.201"},{"key":"10.1016\/j.intimp.2022.109585_b0325","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3389\/fimmu.2019.02342","article-title":"Targeting the Janus Kinase Family in Autoimmune Skin Diseases","volume":"10","author":"Howell","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109585_b0330","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13555-019-00347-w","article-title":"Systemic Treatment of Psoriasis with JAK Inhibitors: A Review","volume":"10","author":"Kvist-Hansen","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2022.109585_b0335","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12885-021-08158-z","article-title":"Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt\/mTOR signaling","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.intimp.2022.109585_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23102592","article-title":"Kaempferol Attenuates ROS-Induced Hemolysis and the Molecular Mechanism of Its Induction of Apoptosis on Bladder Cancer","volume":"23","author":"Wu","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2022.109585_b0345","doi-asserted-by":"crossref","unstructured":"L.X. Xiao HB, Z.K. Liu, Z.F. Luo, Kaempferol inhibits the production of ROS to modulate OPN-\u03b1v\u03b23 integrin pathway in HUVECs, J. Physiol. Biochem. 72(2) (2016) 303-13.","DOI":"10.1007\/s13105-016-0479-3"},{"key":"10.1016\/j.intimp.2022.109585_b0350","doi-asserted-by":"crossref","unstructured":"G.-C.M. Ple\u0144kowska J, P. Mozolewski, Oxidative Stress as an Important Contributor to the Pathogenesis of Psoriasis, Int. J. Molecular Sci. 21(17) (2020).","DOI":"10.3390\/ijms21176206"},{"issue":"6","key":"10.1016\/j.intimp.2022.109585_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108368","article-title":"Intramacrophage ROS Primes the Innate Immune System via JAK\/STAT and Toll Activation","volume":"33","author":"Chakrabarti","year":"2020","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.intimp.2022.109585_b0360","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/13510002.2019.1658377","article-title":"Salidroside inhibits MAPK, NF-kappaB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation","volume":"24","author":"Xu","year":"2019","journal-title":"Redox Rep."},{"key":"10.1016\/j.intimp.2022.109585_b0365","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1038\/emm.2013.157","article-title":"Anti-inflammatory activity of compounds isolated from Astragalus sinicus L. in cytokine-induced keratinocytes and skin","volume":"46","author":"Kim","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2022.109585_b0370","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621956","article-title":"Major Role of the IL17\/23 Axis in Psoriasis Supports the Development of New Targeted Therapies","volume":"12","author":"Bugaut","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.109585_b0375","article-title":"The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses","volume":"34","author":"Michelle","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2022.109585_b0380","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594735","article-title":"The IL-23\/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109585_b0385","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191397","article-title":"Interleukin-17 cytokines: Effectors and targets in psoriasis-A breakthrough in understanding and treatment","volume":"217","author":"Prinz","year":"2020","journal-title":"J. Exp. Med."},{"issue":"35","key":"10.1016\/j.intimp.2022.109585_b0390","doi-asserted-by":"crossref","first-page":"E3669","DOI":"10.1073\/pnas.1405798111","article-title":"Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice","volume":"111","author":"Khmaladze","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922010700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922010700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:46:06Z","timestamp":1761587166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922010700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":78,"alternative-id":["S1567576922010700"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109585","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kaempferol modulates IFN-\u03b3 induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesions","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109585"}}